Home
>
National Drug Code (NDC)
>
Dilantin-125
Dilantin-125 - 0071-2214-20 - (PHENYTOIN)
Drug Information of Dilantin-125
| Product NDC: | 0071-2214 |
| Proprietary Name: | Dilantin-125 |
| Non Proprietary Name: | PHENYTOIN |
| Active Ingredient(s): | 125 mg/5mL & nbsp; PHENYTOIN |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dilantin-125
| Product NDC: | 0071-2214 |
| Labeler Name: | Parke-Davis Div of Pfizer Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA008762 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19530106 |
Package Information of Dilantin-125
| Package NDC: | 0071-2214-20 |
| Package Description: | 237 mL in 1 BOTTLE (0071-2214-20) |
NDC Information of Dilantin-125
| NDC Code | 0071-2214-20 |
| Proprietary Name | Dilantin-125 |
| Package Description | 237 mL in 1 BOTTLE (0071-2214-20) |
| Product NDC | 0071-2214 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PHENYTOIN |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19530106 |
| Marketing Category Name | NDA |
| Labeler Name | Parke-Davis Div of Pfizer Inc |
| Substance Name | PHENYTOIN |
| Strength Number | 125 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
